aTyr Pharma, Inc. short interest in 2026
In 2026, aTyr Pharma, Inc.'s disclosed short interest ran from 21.77% of shares outstanding on 15 Jan 2026 to 10.88% on 15 Sep 2026, a change of -10.89 percentage points. The year's high was 21.82% on 15 May 2026 and its low 8.44% on 15 Jul 2026, averaging 16.85% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.28 days on 30 Apr 2026. Full history: aTyr Pharma, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 21.77% (15 Jan 2026)
- End of year
- 10.88% (15 Sep 2026)
- Change
- -10.89 pp
- High
- 21.82% (15 May 2026)
- Low
- 8.44% (15 Jul 2026)
- Average
- 16.85%
- Highest days to cover
- 25.28 (30 Apr 2026)
- SEC filings marked
- 7
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 21.77% | 14.17 | |
| 30 Jan 2026 | 20.85% | 7.72 | |
| 13 Feb 2026 | 20.29% | 8.42 | |
| 27 Feb 2026 | 19.19% | 11.60 | |
| 13 Mar 2026 | 19.34% | 16.15 | 10-K filed, results (8-K) |
| 31 Mar 2026 | 20.01% | 19.59 | |
| 15 Apr 2026 | 20.28% | 21.16 | |
| 30 Apr 2026 | 20.24% | 25.28 | |
| 15 May 2026 | 21.82% | 4.48 | results (8-K), 10-Q filed, results (8-K) |
| 29 May 2026 | 20.59% | 5.01 | |
| 15 Jun 2026 | 18.88% | 9.76 | |
| 30 Jun 2026 | 14.79% | 5.07 | |
| 15 Jul 2026 | 8.44% | 4.25 | |
| 31 Jul 2026 | 9.92% | 11.76 | |
| 14 Aug 2026 | 9.63% | 14.72 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 9.46% | 16.07 | |
| 15 Sep 2026 | 10.88% | 11.90 |
See also: aTyr Pharma, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.